Please enable JavaScript to continue using this application.

Compare $HOWL vs $TIL | Chartloom

Compare

$HOWL vs $TIL

Werewolf Therapeutics Inc · Instil Bio Inc

HOWL

Werewolf Therapeutics Inc

TIL

Instil Bio Inc

Compare $HOWL vs $TIL

Comparing Werewolf Therapeutics Inc and Instil Bio Inc

HOWLWerewolf Therapeutics Inc

TILInstil Bio Inc

HOWLWerewolf Therapeutics Inc

Market cap

$48M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

51.9%

52W performance

-47.9%

FCF yield

-63.3%

TILInstil Bio Inc

Market cap

$46M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-40.2%

52W performance

-67.2%

FCF yield

-73.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HOWL

TIL

Detailed metrics comparison

HOWL

Werewolf Therapeutics Inc

TIL

Instil Bio Inc

Market Cap

HOWL$48M

TIL$46M

Enterprise Value

HOWL$26M

TIL$125M

Price

HOWL$0.98

TIL$6.74

P/E Ratio

HOWLN/A

TILN/A

P/S Ratio

HOWL2.27x

TIL0.00x

EV/Sales

HOWL1.22x

TIL0.00x

EV/EBITDA

HOWL0.00x

TIL0.00x

P/B Ratio

HOWL2.77x

TIL0.46x

P/FCF Ratio

HOWLN/A

TILN/A

EV/FCF

HOWL-0.85x

TIL-3.73x

PEG Ratio

HOWLN/A

TILN/A

Forward P/E (NTM)

HOWLN/A

TILN/A

Forward P/S (NTM)

HOWLN/A

TILN/A

Revenue (TTM)

HOWL$21M

TIL$0

Revenue Growth (YoY)

HOWLN/A

TILN/A

Forward Rev Growth

HOWL0.0%

TIL0.0%

Gross Margin (TTM)

HOWL0.0%

TIL0.0%

Operating Margin (TTM)

HOWL18.1%

TIL0.0%

EBITDA Margin (TTM)

HOWL-104.4%

TIL0.0%

Net Margin (TTM)

HOWL-164.8%

TIL0.0%

FCF Margin (TTM)

HOWL-143.6%

TILN/A

Net Income (TTM)

HOWL$-35M

TIL$-30M

FCF (TTM)

HOWL$-30M

TIL$-34M

EPS (TTM)

HOWL-$0.71

TIL-$4.46

ROE (TTM)

HOWL-16698.0%

TIL-2678.0%

ROA (TTM)

HOWL-5988.0%

TIL-1489.0%

ROIC (TTM)

HOWL-8259.0%

TIL-1529.0%

Cash

HOWL$22M

TIL$6M

Debt

HOWL$0

TIL$85M

Net Cash/Debt

HOWL$22M

TIL$-80M

Current Ratio (TTM)

HOWL2.91x

TIL21.67x

Quick Ratio (TTM)

HOWL2.80x

TIL21.19x

Debt/Equity (TTM)

HOWL1.14x

TIL0.79x

Debt/Assets (TTM)

HOWL0.0%

TIL0.0%

Interest Coverage (TTM)

HOWLN/A

TILN/A

Net Debt/EBITDA (TTM)

HOWL0.00x

TIL0.00x

Beta

HOWL0.57

TIL1.90

52W Performance

HOWL-47.9%

TIL-67.2%

YTD Performance

HOWL51.9%

TIL-40.2%

% from 52W High

HOWL-49.4%

TIL-69.3%

% from 52W Low

HOWL262.8%

TIL18.9%

Asset Turnover (TTM)

HOWL0.87x

TIL0.00x

FCF Yield (TTM)

HOWL-63.3%

TIL-73.6%

Earnings Yield (TTM)

HOWL-72.7%

TIL-66.3%

Dividend Yield (TTM)

HOWLN/A

TILN/A

Rule of 40

HOWL-143.6

TIL0.0

EV/GP/RG

HOWLN/A

TILN/A

Ticker research

View HOWL research View TIL research

Metric	HOWL Werewolf Therapeutics Inc	TIL Instil Bio Inc
Market & Valuation
Market Cap	$48M	$46M
Enterprise Value	$26M	$125M
Price	$0.98	$6.74
P/E Ratio	N/A	N/A
P/S Ratio	2.27x	0.00x
EV/Sales	1.22x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.77x	0.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.85x	-3.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$21M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	18.1%	0.0%
EBITDA Margin (TTM)	-104.4%	0.0%
Net Margin (TTM)	-164.8%	0.0%
FCF Margin (TTM)	-143.6%	N/A
Net Income (TTM)	$-35M	$-30M
FCF (TTM)	$-30M	$-34M
EPS (TTM)	-$0.71	-$4.46
ROE (TTM)	-16698.0%	-2678.0%
ROA (TTM)	-5988.0%	-1489.0%
ROIC (TTM)	-8259.0%	-1529.0%
Financial Health
Cash	$22M	$6M
Debt	$0	$85M
Net Cash/Debt	$22M	$-80M
Current Ratio (TTM)	2.91x	21.67x
Quick Ratio (TTM)	2.80x	21.19x
Debt/Equity (TTM)	1.14x	0.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	1.90
52W Performance	-47.9%	-67.2%
YTD Performance	51.9%	-40.2%
% from 52W High	-49.4%	-69.3%
% from 52W Low	262.8%	18.9%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.00x
FCF Yield (TTM)	-63.3%	-73.6%
Earnings Yield (TTM)	-72.7%	-66.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-143.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HOWL research	View TIL research

Valuation

P/S Ratio

TIL

0.00x

HOWL

2.27x

EV/FCF

TIL

-3.73x

HOWL

-0.85x

Growth & revenue

Forward Revenue Growth

HOWL

0.0%

TIL

0.0%

Profitability & performance

Gross Margin

HOWL

0.0%

TIL

0.0%

ROE

TIL

-2678.0%

HOWL

-16698.0%

FCF Yield %

HOWL

-63.3%

TIL

-73.6%

52-Week Performance

HOWL

-47.9%

TIL

-67.2%

Detailed metrics comparison

HOWL

Werewolf Therapeutics Inc

TIL

Instil Bio Inc

Market Cap

HOWL$48M

TIL$46M

Enterprise Value

HOWL$26M

TIL$125M

Price

HOWL$0.98

TIL$6.74

P/E Ratio

HOWLN/A

TILN/A

P/S Ratio

HOWL2.27x

TIL0.00x

EV/Sales

HOWL1.22x

TIL0.00x

EV/EBITDA

HOWL0.00x

TIL0.00x

P/B Ratio

HOWL2.77x

TIL0.46x

P/FCF Ratio

HOWLN/A

TILN/A

EV/FCF

HOWL-0.85x

TIL-3.73x

PEG Ratio

HOWLN/A

TILN/A

Forward P/E (NTM)

HOWLN/A

TILN/A

Forward P/S (NTM)

HOWLN/A

TILN/A

Revenue (TTM)

HOWL$21M

TIL$0

Revenue Growth (YoY)

HOWLN/A

TILN/A

Forward Rev Growth

HOWL0.0%

TIL0.0%

Gross Margin (TTM)

HOWL0.0%

TIL0.0%

Operating Margin (TTM)

HOWL18.1%

TIL0.0%

EBITDA Margin (TTM)

HOWL-104.4%

TIL0.0%

Net Margin (TTM)

HOWL-164.8%

TIL0.0%

FCF Margin (TTM)

HOWL-143.6%

TILN/A

Net Income (TTM)

HOWL$-35M

TIL$-30M

FCF (TTM)

HOWL$-30M

TIL$-34M

EPS (TTM)

HOWL-$0.71

TIL-$4.46

ROE (TTM)

HOWL-16698.0%

TIL-2678.0%

ROA (TTM)

HOWL-5988.0%

TIL-1489.0%

ROIC (TTM)

HOWL-8259.0%

TIL-1529.0%

Cash

HOWL$22M

TIL$6M

Debt

HOWL$0

TIL$85M

Net Cash/Debt

HOWL$22M

TIL$-80M

Current Ratio (TTM)

HOWL2.91x

TIL21.67x

Quick Ratio (TTM)

HOWL2.80x

TIL21.19x

Debt/Equity (TTM)

HOWL1.14x

TIL0.79x

Debt/Assets (TTM)

HOWL0.0%

TIL0.0%

Interest Coverage (TTM)

HOWLN/A

TILN/A

Net Debt/EBITDA (TTM)

HOWL0.00x

TIL0.00x

Beta

HOWL0.57

TIL1.90

52W Performance

HOWL-47.9%

TIL-67.2%

YTD Performance

HOWL51.9%

TIL-40.2%

% from 52W High

HOWL-49.4%

TIL-69.3%

% from 52W Low

HOWL262.8%

TIL18.9%

Asset Turnover (TTM)

HOWL0.87x

TIL0.00x

FCF Yield (TTM)

HOWL-63.3%

TIL-73.6%

Earnings Yield (TTM)

HOWL-72.7%

TIL-66.3%

Dividend Yield (TTM)

HOWLN/A

TILN/A

Rule of 40

HOWL-143.6

TIL0.0

EV/GP/RG

HOWLN/A

TILN/A

Ticker research

View HOWL research View TIL research

Metric	HOWL Werewolf Therapeutics Inc	TIL Instil Bio Inc
Market & Valuation
Market Cap	$48M	$46M
Enterprise Value	$26M	$125M
Price	$0.98	$6.74
P/E Ratio	N/A	N/A
P/S Ratio	2.27x	0.00x
EV/Sales	1.22x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.77x	0.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.85x	-3.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$21M	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	18.1%	0.0%
EBITDA Margin (TTM)	-104.4%	0.0%
Net Margin (TTM)	-164.8%	0.0%
FCF Margin (TTM)	-143.6%	N/A
Net Income (TTM)	$-35M	$-30M
FCF (TTM)	$-30M	$-34M
EPS (TTM)	-$0.71	-$4.46
ROE (TTM)	-16698.0%	-2678.0%
ROA (TTM)	-5988.0%	-1489.0%
ROIC (TTM)	-8259.0%	-1529.0%
Financial Health
Cash	$22M	$6M
Debt	$0	$85M
Net Cash/Debt	$22M	$-80M
Current Ratio (TTM)	2.91x	21.67x
Quick Ratio (TTM)	2.80x	21.19x
Debt/Equity (TTM)	1.14x	0.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.57	1.90
52W Performance	-47.9%	-67.2%
YTD Performance	51.9%	-40.2%
% from 52W High	-49.4%	-69.3%
% from 52W Low	262.8%	18.9%
Efficiency & Yields
Asset Turnover (TTM)	0.87x	0.00x
FCF Yield (TTM)	-63.3%	-73.6%
Earnings Yield (TTM)	-72.7%	-66.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-143.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HOWL research	View TIL research